Investing

Relmada Therapeutics : RLMD

RLMD

Stock Data

$7.64

$0.12 (1.60%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Relmada Therapeutics Inc is a biotech firm based in Coral Gables, Florida, dedicated to creating new treatments for central nervous system (CNS) diseases and other disorders. Its flagship project, Esmethadone, is a novel compound in advanced clinical trials aimed at addressing major depressive disorder in adults. Founded in 2004, Relmada is at the forefront of exploring innovative therapies to improve mental health outcomes.

All Relmada Therapeutics Articles

2 Articles

Eric Bleeker | Mar 9, 2026 at 7:00 PM EDT

50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today

Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada…

Lee Jackson | Dec 22, 2025 at 8:12 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: BlackSky Technology, Cummins, Lamb Watson, Ollie’s Bargain Outlet, Sealed Air, Volaris, and More

Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding…